PCN93 Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors With Sunitinib in Patients With Disease Progression- Cost-Utility and Cost-Effectiveness Analysis
Abstract
Authors
J. Walczak M. Garbacka J. Zawieja P. Prząda-Machno J. Kroc